Allergan Names Douglas S. Ingram President

IRVINE, Calif.—Allergan, Inc. (NYSE:AGN) has named Douglas S. Ingram as president. In this newly established role, Ingram will report directly to David E.I. Pyott, chairman of the board and CEO.   He will lead the company's global commercial operations, with responsibility for the company's broad portfolio of pharmaceutical, consumer and medical device products including leading ophthalmology products such as Restasis, Lumigan, Alphagan, Combigan, Ganfort, Optive and Ozurdex.   Read more